Bristol-based biotech startup Ferrix has announced that it has signed a partnership to conduct the first UK poultry trials of its flagship product. AB Agri, A global agri-food business focused on food security and sustainability.
AB Agri will test a live bacterial feed additive, FEREX FX 856 in broiler chickens, to assess its impact on health, well-being and productivity in farmed birds. If the test is successful, AB Agri will begin working to develop the FX856 into a commercial product. Pharix is managing the manufacturing process and consulting throughout the live trial period.
FX 856 is a living bacterium developed by University of Bristol Spin-out ferrex, which is proven to survive and thrive in the belly of an animal, which is stressed, an area where currently available probiotics fail. As the global agricultural sector continues to reduce and remove antibiotics and zinc oxide from animal feed, maintaining gut health can become more challenging and it is important that growers have alternative solutions.
Elevating Farix’s Tech
The trials of FX 856 of A. agri are intended to investigate its efficacy in poultry, as it consistently exhibits anti-inflammatory effects and has been shown to reduce the effects of stress on the GI system in other species. If successful, the product is expected to reduce the incidence and be severeEpisodes of poor gut health, improving animal health and well-being and improving efficiency and productivity.
CEO of Farex, Drs. Jennifer Bailey commented, “We are delighted to partner with AB Agri on this very exciting project. The company has a great reputation for leading global bio-tech innovation advances that have animal health and well-being. They are the ideal partners for the first large-scale trial of our novel, stress-responsive bacterial product. “
“The search for the best technology continues to meet the needs of our customers to meet our objectives,” says Dr. Nell Massey O’Neill, Agri’s Director of Innovation. “” Collaboration is key to our innovation model and we are really excited with the team at Farex to investigate this exciting new probiotic bacteria. “
Dr. Mike Bedford, AB Vista’s R&D director, AB Agri’s Feed Additive Business, says: “Within animal nutrition, increasingly, attention is not only to nutrition provided directly to the animal, but because of the important role the gut microbiota plays. It also plays a role in intestinal health and immune function. We have been developing our knowledge in this field for quite some time, and we see this partnership as expanding that knowledge base to bring it into the global animal nutrition industry.
You can find more information about Pherix and its mission in their Silicon Gorge profile here.